Kraig Biocraft Laboratories, Inc.

KBLB ·Basic Materials, Specialty Chemicals, United States
Analysis › Moat Score

Moat Score — Kraig Biocraft Laboratories, Inc.

Total Moat Score 4 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 3 / 5 Kraig Biocraft's genetically engineered silkworm technology that produces spider silk proteins (branded Monster Silk and Dragon Silk) is a specific, patentable technical achievement, though it remains commercially unproven at scale.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 1 / 5 The company claims its silkworm-based approach is more cost-effective than bioreactor-based competitors like Spiber and AMSilk, but with $0 revenue and no commercial-scale production, this claim is unverified.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 0 / 5 With zero revenue in both 2023 and 2024, Kraig Biocraft has no demonstrated pricing power; Dragon Silk yarn sales remain only a planned future milestone.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 0 / 5 Recombinant fiber production has no network effect; neither additional customers nor additional silkworm production increases the value of the product to others.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 0 / 5 With no commercial customers yet, there are no established switching costs; any future textile or materials customers would face minimal lock-in at this stage.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 0 / 5 The company has no commercial-scale production; its Vietnamese Prodigy Textiles facility is still being scaled toward larger-volume output, and better-capitalized competitors could out-invest it in scale-up.